Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biomarker Research|September 25, 2020
Epigenetic based synthetic lethal strategies in human cancersAiai Gao, Mingzhou Guo
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|September 27, 2016
[Mitochondrial signal peptide guides EGFP-GRP75 fusion proteins into mitochondria]Hang Chen, Xiuran Niu, Aiai Gao, et al.
Cancer Biology & Therapy|January 16, 2024
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signalingQian Du, Meiying Zhang, Aiai Gao, et al.
Epigenomics|July 18, 2024
Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signalingJing Zhou, Meiying Zhang, Aiai Gao, et al.
Biomarker Research|November 8, 2019
Epigenetic heterogeneity in cancerMingzhou Guo, Yaojun Peng, Aiai Gao, et al.
Epigenomics|October 30, 2025
Defect of MLH1 expression sensitized esophageal squamous cell carcinoma cells to Polθ inhibitorBo Zhou, Meiying Zhang, Cheng Zhu, et al.
Epigenomics|December 14, 2023
RASSF1A promotes ATM signaling and RASSF1A methylation is a synthetic lethal marker for ATR inhibitorsAiai Gao, Panpan Bai, Meiying Zhang, et al.
Cancer Biology & Therapy|March 25, 2026
Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitorYuan Li, Aiai Gao, Yuanxin Yao, et al.
Journal of Translational Internal Medicine|July 31, 2024
Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancerFengna Liu, Aiai Gao, Meiying Zhang, et al.
Cancer Science|May 1, 2021
Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancerWushuang Du, Aiai Gao, James G Herman, et al.
Pageof 2